You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

resectable pancreatic cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Candidates for Neoadjuvant Treatment in Resectable Pancreatic

Completed
  • Pancreatic Cancer
  • Neoadjuvant
  • Neoadjuvant treatment
  • (no location specified)
Nov 9, 2023

Pancreatic Cancer Trial in Aurora (TTI-101)

Not yet recruiting
  • Pancreatic Cancer
  • Aurora, Colorado
    University of Colorado
Nov 30, 2023

Resectable Pancreatic Cancer Trial in Tianjin (AG Followed by FOLFIRINOX)

Recruiting
  • Resectable Pancreatic Cancer
  • AG Followed by FOLFIRINOX
  • Tianjin, Tianjin, China
    Rui Liu
Jan 8, 2023

Pancreatic Cancer, Stage IB, Pancreatic Cancer, Stage IIA, Pancreatic Cancer, Stage IIB Trial in Shanghai (sintilimab,

Not yet recruiting
  • Pancreatic Cancer, Stage IB
  • +3 more
  • Shanghai, Shanghai, China
    Zhongshan Hospital
Jan 4, 2023

Pancreatic Cancer, Surgery, Metastasis Trial (Histamine DiHCl (HDC), Interleukin-2 (IL-2))

Not yet recruiting
  • Pancreatic Cancer
  • +3 more
  • Histamine Dihydrochloride (HDC)
  • Interleukin-2 (IL-2)
  • (no location specified)
Mar 31, 2023

Pancreatic Cancer Trial in Seoul (Preoperative Stereotactic body radiation therapy (SBRT), Pancreatic resection, Adjuvant

Recruiting
  • Pancreatic Cancer
  • Preoperative Stereotactic body radiation therapy (SBRT), Pancreatic resection, Adjuvant Chemotherapy
  • Seoul, Korea, Republic of
    Yonsei University Health System, Severance Hospital
Jan 10, 2023

Pancreatic Cancer Trial in Houston (Enhanced Usual Care, Tele-supervised resistance exercises)

Not yet recruiting
  • Pancreatic Cancer
  • Enhanced Usual Care
  • Tele-supervised resistance exercises
  • Houston, Texas
    M D Anderson Cancer Center
Apr 20, 2023

Pancreatic Carcinoma Trial in Nanjing (Toripalimab, Gemcitabine, Nab paclitaxel)

Not yet recruiting
  • Pancreatic Carcinoma
  • Nanjing, Jiangsu, China
    The Affiliated Nanjing Drum Tower Hospital of Nanjing University
Oct 6, 2023

ctDNA in Resectable and Borderline Resectable Pancreatic Cancer

Recruiting
  • Pancreatic Cancer
  • SIGNATERA™ ctDNA testing
  • Fairfax, Virginia
    Inova Schar Cancer Institute
Oct 26, 2022

Pancreas Cancer, Pancreas Adenocarcinoma, Lymph Node Metastasis Trial in Denmark, Sweden (PALN resection)

Recruiting
  • Pancreas Cancer
  • +2 more
  • PALN resection
  • Odense, Denmark
  • +5 more
Sep 26, 2023

Pancreas Cancer, Non-Resectable Pancreas Carcinoma Trial in Aalborg (Gemcitabine, Nab paclitaxel)

Not yet recruiting
  • Pancreas Cancer
  • Non-Resectable Pancreas Carcinoma
  • Aalborg, Denmark
    Department of Oncology, Aalborg University Hospital
May 1, 2023

Borderline Resectable Pancreatic Cancer Trial in Verona (Intraoperative radiotherapy)

Suspended
  • Borderline Resectable Pancreatic Cancer
  • Intraoperative radiotherapy
  • Verona, Italy
    General and Pancreatic Surgery Unit, Pancreas Institute, Univers
Nov 1, 2022

Pancreatic Carcinoma Trial in Nanjing (Tislelizumab, Gemcitabine, Nab paclitaxel)

Recruiting
  • Pancreatic Carcinoma
  • Nanjing, Jiangsu, China
    The Affiliated Nanjing Drum Tower Hospital of Nanjing University
Dec 1, 2022

Pancreatic Cancer, Cancer of the Pancreas, Pancreas Cancer Trial in Saint Louis (CDX-301, CDX-1140, Research blood draw)

Recruiting
  • Pancreatic Cancer
  • +2 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Jan 17, 2023

Resectable Pancreatic Cancer, Ductal Adenocarcinoma of the Pancreas Trial in Ulm (perioperative nab-paclitaxel/gemcitabine,

Completed
  • Resectable Pancreatic Cancer
  • Ductal Adenocarcinoma of the Pancreas
  • perioperative nab-paclitaxel/gemcitabine
  • adjuvant nab-paclitaxel/gemcitabine
  • Ulm, Germany
    University of Ulm, Dept. of Internal Medicine I
Nov 21, 2022

Pancreatic Adenocarcinoma, Pancreatic Cancer Resectable Trial in Cádiz (Folfirinox and Stereotactic Body Radiotherapy)

Recruiting
  • Pancreatic Adenocarcinoma
  • Pancreatic Cancer Resectable
  • Folfirinox and Stereotactic Body Radiotherapy
  • Cádiz, Spain
    Hospital Puerta del Mar
Aug 5, 2022

Pancreatic Cancer Trial in Saint Louis (Daily Adaptive External Beam Radiation Therapy)

Recruiting
  • Pancreatic Cancer
  • Daily Adaptive External Beam Radiation Therapy
  • Saint Louis, Missouri
    Washington University, St. Louis
Mar 7, 2023

Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Resectable Pancreatic Adenocarcinoma Trial in Netherlands (Leucovorin

Recruiting
  • Pancreatic Cancer
  • +2 more
  • Leucovorin Calcium
  • +4 more
  • 's-Hertogenbosch, Netherlands
  • +19 more
Jan 6, 2023

Pancreatic Cancer Using CA19-9 and Fecal Elastase

Active, not recruiting
  • Paancreatic Cancer
    • Seoul, Korea, Republic of
      Gangnam Severance Hospital
    Jun 27, 2023

    Pancreatic Cancer Trial in Tianjin (surufatinib + gemcitabine + nab-paclitaxel)

    Recruiting
    • Pancreatic Cancer
    • surufatinib + gemcitabine + nab-paclitaxel
    • Tianjin, Tianjin, China
      Tianjin Medical University Cancer Institute and Hospital
    Jun 15, 2023

    Pancreatic Cancer Trial in Houston (MRx0518, Hypofractionated Preoperative Radiation)

    Active, not recruiting
    • Pancreatic Cancer
    • MRx0518
    • Hypofractionated Preoperative Radiation
    • Houston, Texas
      MD Anderson Cancer Center
    Jul 5, 2022

    ctDNA Assay in Patients With Resectable Pancreatic Cancer

    Recruiting
    • Pancreas Cancer
      • Oklahoma City, Oklahoma
        University of Oklahoma
      Jun 10, 2022

      Pancreatic Cancer Trial in Philadelphia (Paricalcitol)

      Terminated
      • Pancreatic Cancer
      • Philadelphia, Pennsylvania
        Abramson Cancer Center of the University of Pennsylvania
      Mar 29, 2022

      Pancreatic Adenocarcinoma, Resectable Pancreatic Cancer Trial (Nab paclitaxel, Gemcitabine, NovoTTF-200T)

      Not yet recruiting
      • Pancreatic Adenocarcinoma
      • Resectable Pancreatic Cancer
      • Nab paclitaxel
      • +2 more
      • (no location specified)
      Dec 5, 2022

      Early Stage Pancreatic Cancer Who Have Undergone Genetic Testing

      Terminated
      • Pancreatic Adenocarcinoma
      • +2 more
      • Germline genetic testing
      • San Francisco, California
        Invitae SF
      Dec 5, 2022